Lefamulin

Fidelia Bernice, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS
Lefamulin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

NON-FDA APPROVED USES

  • In vitro activity has been demonstrated against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium, multidrug-resistant Neisseria gonorrhoeae, and Mycoplasma genitalium.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

NON-FDA APPROVED USES

  • In vitro activity has been demonstrated against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium, multidrug-resistant Neisseria gonorrhoeae, and Mycoplasma genitalium.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: July 3, 2020